A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer
NCT00068380
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
NIH
Sponsor class
Conditions
Recurrent Gastric Cancer
Stage IV Gastric Cancer
Interventions
DRUG:
imatinib mesylate
OTHER:
laboratory biomarker analysis
Sponsor
National Cancer Institute (NCI)